KALA BIO, Inc. - KALA

Sector: Healthcare · Industry: Pharmaceutical Preparations
Website: No information yet · Social: No information yet

Company profile

Powered by TradingView

Quarter snapshot

Latest / Compare
Q4 2025 · Q3 2025
Value (USD)
Total reported value ($000)
$1.569M
QoQ value delta ($000)
-$1.112M (-41.48%)
Implied price effect (QoQ)
-63.97%
Shares
Total shares
2,840,573
QoQ shares delta
+1,091,524 (+62.41%)
Total shares held by funds (by quarter)

Market chart (KALA)

Powered by TradingView
Interactive chart by TradingView.

Top holders (Q4 2025)

Top 25 only Full list
Early Q1 2026 data: only 1 institutional holders reported so far. More will appear as funds file with the SEC.
Manager Value ($000) Shares % of 13F
BAKER BROS. ADVISORS LP 1,002 1,804,055 0.01%
Woodline Partners LP 124 224,174 0.0%
JANE STREET GROUP, LLC 80 144,347 0.0%
ADAR1 Capital Management, LLC 78 141,480 0.01%
VANGUARD GROUP INC 50 91,009 0.0%
Virtu Financial LLC 48 85,505 0.0%
GEODE CAPITAL MANAGEMENT, LLC 34 61,161 0.0%
CITADEL ADVISORS LLC 31 56,381 0.0%
RENAISSANCE TECHNOLOGIES LLC 22 40,905 0.0%
STATE STREET CORP 15 28,576 0.0%
XTX Topco Ltd 15 28,278 0.0%
TWO SIGMA INVESTMENTS, LP 14 26,900 0.0%
UBS Group AG 13 23,910 0.0%
BlackRock, Inc. 11 21,407 0.0%
TWO SIGMA SECURITIES, LLC 7 13,105 0.0%
NORTHERN TRUST CORP 6 11,524 0.0%
CITIGROUP INC 6 11,596 0.0%
StoneX Group Inc. 6 12,255 0.0%
SG Americas Securities, LLC 6 10,359 0.0%
Covestor Ltd 1 1,264 0.0%
JPMORGAN CHASE & CO 0 51 0.0%
BANK OF AMERICA CORP /DE/ 0 296 0.0%
MORGAN STANLEY 0 607 0.0%
MAI Capital Management 0 300 0.0%
Cheviot Value Management, LLC 0 153 0.0%